Skip to main content
RxCopaysGet started

Affordability Check

How to afford AQVESME

Generic name: mitapivat

Pick how you're covered. We'll show you the cheapest legitimate way to get AQVESME — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.

How are you covered for prescriptions?

Pick the one that fits you. We'll show you the cheapest way to get this drug.

Pick an option above to see your specific path.

Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.

About AQVESME and its cost

AQVESME (mitapivat) is a prescription medication manufactured by Agios Pharmaceuticals for the treatment of anemia in adults with alpha- or beta-thalassemia. Thalassemia is an inherited blood disorder where the body produces abnormal or insufficient hemoglobin, the protein in red blood cells that carries oxygen. This leads to chronic anemia, fatigue, weakness, and in severe cases, the need for regular blood transfusions and ongoing monitoring for life-threatening complications. AQVESME works as a pyruvate kinase (PK) activator — it enhances the activity of the pyruvate kinase enzyme in red blood cells, which helps stabilize the cells and improve hemoglobin production. By boosting this natural metabolic pathway, AQVESME helps the body produce healthier red blood cells, raising hemoglobin levels and reducing the burden of transfusions in patients who depend on them. AQVESME is the only FDA-approved medication for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, making it a first-of-its-kind treatment option. It was approved by the FDA in December 2025 and became available in the United States in late January 2026. The same active ingredient, mitapivat, is also marketed under the brand name PYRUKYND for a different condition — pyruvate kinase deficiency.

AQVESME is made by Agios. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.

Common questions

What's the cheapest way to afford AQVESME?

It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.

Can I use a copay card with Medicare for AQVESME?

No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Agios has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.

Does my Medicare Part D plan cover AQVESME?

Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.

How long does a Patient Assistance Program take?

Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.

What if I have a high-deductible plan?

For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.

Are there charity grants for Beta Thalassemia?

Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.

More about AQVESME